Hennepin County Medical Center and the University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN, USA.
Clin Biochem. 2010 Aug;43(12):1034-6. doi: 10.1016/j.clinbiochem.2010.05.014. Epub 2010 May 27.
This study determined the serum 99th percentile reference value for cTnI measured using the high sensitivity Erenna cTnI assay.
Serum was obtained from healthy adults (n=348); aged 18-76 years of which 147 were males and 201 were females. Nonparametric analysis was performed to determine the 99th percentiles.
For all subjects, the 99th percentile was 10.19 ng/L; mean concentration=1.45 ng/L, range=0.2 to 34.56 ng/L. By gender, the male and female 99th percentile values were as follows: male=16.58 ng/L, mean concentration=1.72 ng/L, and female=9.36 ng/L, mean concentration=1.25 ng/L, respectively (p=0.108).
cTnI measured by the high-sensitivity Erenna cTnI assay measured 100% of normal subjects, allowing prospective diagnostic and risk assessment studies to be performed, which are essential for the early detection of cardiac disease and for the management of patients presenting with symptoms suggestive of acute coronary syndrome.
本研究旨在确定使用高敏 Erenna cTnI 检测方法测定的 cTnI 血清第 99 百分位参考值。
从健康成年人(n=348)中获得血清;年龄 18-76 岁,其中 147 名为男性,201 名为女性。采用非参数分析确定第 99 百分位值。
所有受试者的第 99 百分位值为 10.19ng/L;平均浓度=1.45ng/L,范围为 0.2-34.56ng/L。按性别,男性和女性的第 99 百分位值分别为:男性=16.58ng/L,平均浓度=1.72ng/L,女性=9.36ng/L,平均浓度=1.25ng/L(p=0.108)。
使用高敏 Erenna cTnI 检测方法测定的 cTnI 可检测 100%的正常受试者,可进行前瞻性诊断和风险评估研究,这对于早期发现心脏病和管理出现急性冠状动脉综合征症状的患者至关重要。